A phase 3, randomised controlled trial showed that elective neck dissection improved overall survival by 12.5% and reduced risk of death by 36% when compared with a wait-and-watch approach for therapeutic neck dissection in early, node-negative, oral squamous cell carcinoma.
Presented by Anil K. D’Cruz, MS, DNB, Tata Memorial Hospital, Mumbai, India, at ASCO 2015
European Medical Journal
Advertisement Single Between Content
Advertisement Single Between Content
Advertisement Single Between Content
Website: http://emjreviews.com/
Twitter: https://twitter.com/EMJReviews
Facebook: https://www.facebook.com/emjreviews
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content